Physician profile
Mark D Pool
NPI 1730164435
$3,926.27
in general payments reported to CMS, 2019-2025
8 companies · $237 in 2025
The $237 reported for 2025 was more than what 81% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $193 · 2021: $39.59 · 2022: $24.48 · 2023: $2,872 · 2024: $388 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,813 · Food and Beverage: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,812.50 |
| Food and Beverage | $684.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,872.34 | 2023 | |
| Medtronic Vascular, INC. | $365.31 | 2019-2020 | |
| Abbott Laboratories | $259.09 | 2024-2025 | Alinity |
| Abiomed | $240.04 | 2022-2025 | Impella |
| Tempus Ai, INC | $102.72 | 2024 | Xt Cdx |
| Medtronic, INC. | $39.59 | 2021 | |
| Cerus Corporation | $30.19 | 2024 | Intercept Blood System For Platelets |
| Haemonetics Corporation | $16.99 | 2025 | Teg6s Hemostasis System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Pool listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.